Document Detail

Anemia in the preterm infant: erythropoietin versus erythrocyte transfusion--it's not that simple.
MedLine Citation:
PMID:  19161869     Owner:  NLM     Status:  MEDLINE    
Since the late 1980s recombinant human erythropoietin (r-EPO) has been studied as an alternative to packed red blood cell (RBC) transfusion for the treatment of anemia of prematurity in very low birth weight infants. Initial trials and reports focused on r-EPO's ability to prevent or treat anemia of prematurity with the goal of eliminating RBC transfusion but achieved limited success. New concerns about the safety of r-EPO administration have emerged. Past cost-benefit analyses of r-EPO administration versus transfusion for the treatment of anemia of prematurity have been nearly balanced. Autologous transfusion, blood-sparing technologies, changes in RBC transfusion technique and safety, and further elucidation of the risk-benefit ratio of r-EPO therapy may change the cost-benefit analysis.
Isabelle Von Kohorn; Richard A Ehrenkranz
Related Documents :
8737229 - Effects of recombinant human erythropoietin in infants with very low birth weights.
10773929 - Efficacy of leucocyte filters during transfusions in preventing the development of anti...
8420319 - First-trimester simple hygroma: cause and outcome.
21391229 - Total brain white matter is a major determinant of iq in adolescents born preterm.
10657829 - Changing practices of red blood cell transfusions in infants with birth weights less th...
21274149 - An update on the sudden infant death syndrome.
17537759 - Infant feeding in the second 6 months of life related to iron status: an observational ...
12521409 - Primary postpartum haemorrhage.
7007849 - Streptococcus group b isolates in a regional hospital area.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Clinics in perinatology     Volume:  36     ISSN:  1557-9840     ISO Abbreviation:  Clin Perinatol     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-01-23     Completed Date:  2009-04-13     Revised Date:  2014-09-24    
Medline Journal Info:
Nlm Unique ID:  7501306     Medline TA:  Clin Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  111-23     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / physiopathology,  therapy*
Erythrocyte Transfusion*
Erythropoietin / therapeutic use*
Hematinics / therapeutic use*
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / therapy*
Infant, Very Low Birth Weight
Recombinant Proteins
Grant Support
Reg. No./Substance:
0/Hematinics; 0/Recombinant Proteins; 11096-26-7/Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Indications for home apnea monitoring (or not).
Next Document:  Evaluation and management of stroke in the neonate.